Signify Research July 25, 2019
Alex Green

This morning saw Health Catalyst announce that it expects its common stock to begin trading on the Nasdaq Global Select Market today. This marks the culmination of a journey that started 11 years ago and provides a great illustration of a start-up that has maximised the potential of the move in healthcare to value-based care. However, the IPO comes at a time where there is some uncertainty gripping the markets it targets and there are several key challenges for Health Catalyst to overcome in order to drive future success. Here’s our take on the company’s journey to this point and its future opportunities and challenges as it transitions from start-up to a publicly traded company.

The Journey to IPO

...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Analytics, Big Data, Digital Health, Investments, Technology, Trends
2024: The Year all the 'Tourist" Investors leave the HealthTech markets?
Report: Figure AI to Raise $675 Million for Human-Like Robots
Frontier Medicines Announces Series C Funding to Advance Development of Next Generation KRAS Blocker
Fundraising Tracker—HealthSnap banks $25M, Cigna backs 9amHealth
Abridge Adds Yale New Haven Health, Picks Up $150M Investment

Share This Article